Brain magnetic resonance spectroscopy in obsessive-compulsive disorder: The importance of considering subclinical symptoms of anxiety and depression

Psychiatry Research - Neuroimaging

Volumn 192, Issue 1, 2011, Pages 45-54

  Bédard, Marie Josée ^a   Chantal, Sophie ^b  

^a UNIVERSITÉ DU QUÉBEC À TROIS RIVIÈRES   (Canada)

^b LAVAL UNIVERSITY   (Canada)

Author keywords

Cerebral metabolism; Neuroimaging; Psychiatric illness

Indexed keywords

CHOLINE; CREATININE; GLUTAMIC ACID; GLUTAMINE; INOSITOL; N ACETYLASPARTIC ACID;

ADULT; ANXIETY; ARTICLE; BRAIN METABOLISM; CINGULATE GYRUS; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DEPRESSION; FEMALE; HUMAN; MALE; NEUROIMAGING; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; OBSESSIVE COMPULSIVE DISORDER; ORBITAL CORTEX; PRIORITY JOURNAL; TEMPORAL LOBE; THALAMUS;

EID: 79952898419     PISSN: 09254927     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pscychresns.2010.10.008     Document Type: Article

References (84)

1. 1H spectroscopy and volumetric MRI study of the corpus striatum in patients with obsessive-compulsive disorder and comparison subjects. The American Journal of Psychiatry 1998, 155:1584-1591.
2. Basso M.R., Bornstein R.A., Carona F., Morton R. Depression accounts for executive function deficits in obsessive-compulsive disorder. Neuropsychiatry, Neuropsychology, and Behavioral Neurology 2001, 14:241-245.
3. Baxter L.R., Phelps M.E., Mazziotta J.C., Guze B.H., Schwartz J.M., Selin C.E. Local cerebral glucose metabolic rates in obsessive-compulsive disorder. A comparison with rates in unipolar depression and in normal controls. Archives of General Psychiatry 1987, 44:211-218.
4. Beck A.T., Epstein N., Brown G., Steer R.A. An inventory for measuring clinical anxiety: psychometric properties. Journal of Consulting and Clinical Psychology 1988, 56:893-897.
5. Beck A.T., Steer R.A., Brown G.K. BDI-II (Beck Depression Inventory II) 1994, Psychological Corporation, San Antonio, TX.
6. Bédard M.-J., Godbout L., Joyal C., Chantal S. Executive functions and the obsessive-compulsive disorder: on the importance of subclinical symptoms and other concomitant factors. Archives of Clinical Neuropsychology 2009, 24:585-598.
7. Benkelfat C., Nordahl T.E., Semple W.E., King A.C., Murphy D.L., Cohen R.M. Local cerebral glucose metabolic rates in obsessive-compulsive disorder. Patients treated with clomipramine. Archives of General Psychiatry 1990, 47:840-848.
8. Bisaga A., Katz J.L., Antonini A., Wright C.E., Margouleff C., Gorman J.M., Eidelberg D. Cerebral glucose metabolism in women with panic disorder. The American Journal of Psychiatry 1998, 155:1178-1183.
9. Boivin I., Marchand A. Évaluation structurée pour les troubles anxieux pour le DSM-IV [Anxiety Disorders Interview Schedule Revised (ADIS-IV)] 1996, Département de psychologie à l'Université du Québec à Montréal, Montréal, Québec.
10. Bolton J., Moore G.J., MacMillan S., Stewart C.M., Rosenberg D.R. Case study: caudate glutamatergic changes with paroxetine persist after medication discontinuation in pediatric OCD. Journal of the American Academy of Child and Adolescent Psychiatry 2001, 40:903-906.
11. Bouvard M., Sauteraud A. Étude de validation et analyse factorielle de la version française de l'échelle d'obsession compulsion de Yale Brown [Validation and factor analysis of the French version of the Yale-Brown Obsessive Compulsive Scale]. Journal de Thérapie Comportementale et Cognitive 1992, 2:18-22.
12. Breiter H.C., Rauch S.L., Kwong K.K., Baker J.R., Weisskoff R.M., Kennedy D.N., Kendrick A.D., Davis T.L., Jiang A., Cohen M.S., Stern C.E., Belliveau J.W., Baer L., O'Sullivan R.L., Savage C.R., Jenike M.A., Rosen B.R. Functional magnetic resonance imaging of symptom provocation in obsessive-compulsive disorder. Archives of General Psychiatry 1996, 53:595-606.
13. Bremner J.D. Stress and brain atrophy. CNS & Neurological Disorders Drug Targets 2006, 5:503-512.
14. Bremner J., Narayan M., Anderson E., Staib L., Miller H., Charney D. Hippocampal volume reduction in major depression. American Journal of Psychiatry 2000, 157:115-118.
15. Brown T.A., Di Nardo P.A., Barlow D.H. Anxiety Disorders Interview Schedule Revised (ADIS-IV) 1994, Graywind Publications, Albany, NY.
16. Caetano S.C., Fonseca M., Olvera R.L., Nicoletti M., Hatch J.P., Stanley J.A., Hunter K., Lafer B., Pliszka S.R., Soares J.C. Proton spectroscopy study of the left dorsolateral prefrontal cortex in pediatric depressed patients. Neuroscience Letters 2005, 384:321-326.
17. Chamberlain S.R., Menzies L., Hampshire A., Suckling J., Fineberg N.A., del Campo N., Aitken M., Craig K., Owen A.M., Bullmore E.T., Robbins T.W., Sahakian B.J. Orbitofrontal dysfunction in patients with obsessive-compulsive disorder and their unaffected relatives. Science 2008, 18:421-422.
18. Charney D.S. Neuroanatomical circuits modulating fear and anxiety behaviors. Acta Psychiatrica Scandinavica Supplementum 2003, 417:38-50.
19. Coupland N.J., Ogilvie C.J., Hegadoren K.M., Seres P., Hanstock C.C., Allen P.S. Decreased prefrontal Myo-inositol in major depressive disorder. Biological Psychiatry 2005, 57:1526-1534.
20. Davidson R.J., Abercrombie H., Nitschke J.B., Putnam K. Regional brain function, emotion and disorders of emotion. Current Opinion in Neurobiology 1999, 9:228-234.
21. De Cristofaro M.T., Sessarego A., Pupi A., Biondi F., Faravelli C. Brain perfusion abnormalities in drug-naive, lactate-sensitive panic patients: a SPECT study. Biological Psychiatry 1993, 33:505-512.
22. de Geus F., Denys D.A., Sitskoorn M.M., Westenberg H.G. Attention and cognition in patients with obsessive-compulsive disorder. Psychiatry and Clinical Neurosciences 2007, 61:45-53.
23. Ebert D., Speck O., König A., Berger M., Hennig J., Hohagen F. 1H-magnetic resonance spectroscopy in obsessive-compulsive disorder: evidence for neuronal loss in the cingulate gyrus and the right striatum. Psychiatry Research: Neuroimaging 1997, 74:173-176.
24. Fitzgerald K.D., Moore G.J., Paulson L.A., Stewart C.M., Rosenberg D.R. Proton spectroscopic imaging of the thalamus in treatment-naive pediatric obsessive-compulsive disorder. Biological Psychiatry 2000, 47:174-182.
25. Fitzgerald K.D., Welsh R.C., Gehring W.J., Abelson J.L., Himle J.A., Liberzon I., Taylor S.F. Error-related hyperactivity of the anterior cingulate cortex in obsessive-compulsive disorder. Biological Psychiatry 2005, 57:287-294.
26. Frances A., Docherty J.P., Kahn D.A. Treatment of obsessive-compulsive disorder. Journal of Clinical Psychiatry 1997, 58:5-72.
27. Freeston M.H., Ladouceur R., Thibodeau N., Gagnon F., Rhéaume J. L'inventaire d'anxiete de Beck et propriétés psychométriques [The Beck Anxiety Inventory: Psychometric properties of a French translation]. L'Encephale 1994, 20:47-55.
28. 1H-magnetic resonance spectroscopy at 1.5 Tesla. Journal of Psychiatric Research 1998, 32:411-420.
29. Fux M., Levine J., Aviv A., Belmaker R.H. Inositol treatment of obsessive-compulsive disorder. The American Journal of Psychiatry 1996, 153:1219-1221.
30. Gehring W.J., Himle J., Nisenson L.G. Action-monitoring dysfunction in obsessive-compulsive disorder. Psychological Science: A Journal of the American Psychological Society 2000, 11:1-6.
31. Goodman W.K., Price L.H., Rasmussen S.A., Mazure C., Fleischmann R.L., Hill C.L., Heninger G.R., Charney D.S. The Yale-Brown Obsessive Compulsive Scale. Development, use, and reliability. Archives of General Psychiatry 1989, 46:1006-1011.
32. Griffin J.L., Bollard M., Nicholson J.K., Bhakoo K. Spectral profiles of cultured neuronal and glial cells derived from HRMAS (1)H NMR spectroscopy. NMR in Biomedicine 2002, 15:375-384.
33. 1H-MRS at 3 Tesla. Investigative Radiology 2003, 38:403-408.
34. Gurvits T.V., Gilbertson M.W., Lasko N.B., Orr S.P., Pitman R.K. Neurological status of combat veterans and adult survivors of sexual abuse post-traumatic stress disorder. Annals of the New York Academy of Sciences 1997, 821:468-471.
35. Ham B.-J., Chey J., Yoon S.J., Sung Y., Jeong D.-U., Ju Kim S., Sim M.E., Choi N., Choi I.G., Renshaw P.F., Lyoo I.K. Decreased N-acetyl-aspartate levels in anterior cingulate and hippocampus in subjects with post-traumatic stress disorder: a proton magnetic resonance spectroscopy study. The European Journal of Neuroscience 2007, 25:324-329.
36. Hansen E.S., Hasselbalch S., Law I., Bolwig T.G. The caudate nucleus in obsessive-compulsive disorder. Reduced metabolism following treatment with paroxetine: a PET study. International Journal of Neuropsychopharmacology 2002, 5:1-10.
37. Harvey B.H. The neurobiology and pharmacology of depression. A comparative overview of serotonin selective antidepressants. South African Medical Journal = Suid-Afrikaanse Tydskrif Vir Geneeskunde 1997, 87:540.
38. Hyder F., Patel A.B., Gjedde A., Rothman D.L., Behar K.L., Shulman R.G. Neuronal-glial glucose oxidation and glutamatergic-GABAergic function. Journal of Cerebral Blood Flow Metabolism 2006, 26 (7):865-877.
39. Inventaire de Dépression de Beck (2e Éds) [Beck Depression Inventory (2rd ed.)], 1996. Paris, Éditions du Centre de Psychologie Appliquée [Center for Applied Psychology Editions].
40. Jang J.H., Kwon J.S., Jang D.P., Moon W.J., Lee J.M., Ha T.H., Chung E.C., Kim I.Y., Kim S.I. A proton MRSI study of brain N-acetylaspartate level after 12weeks of citalopram treatment in drug-naive patients with obsessive-compulsive disorder. The American Journal of Psychiatry 2006, 163:1202-1207.
41. Jenike M.A. Neurosurgical treatment of obsessive-compulsive disorder. The British Journal of Psychiatry Supplement 1998, 35:79-90.
42. Kent J.M., Rauch S.L. Neurocircuitry of anxiety disorders. Current Psychiatry Reports 2003, 5:266-273.
43. Kitayama N., Vaccarino V., Kutner M., Weiss P., Bremner J.D. Magnetic resonance imaging (MRI) measurement of hippocampal volume in posttraumatic stress disorder: a meta-analysis. Journal of Affective Disorders 2005, 88:79-86.
44. Kumar A., Thomas A., Lavretsky H., Yue K., Huda A., Curran J., Venkatraman T., Estanol L., Mintz J., Mega M., Toga A. Frontal white matter biochemical abnormalities in late-life major depression detected with proton magnetic resonance spectroscopy. The American Journal of Psychiatry 2002, 159:630-636.
45. Kwon J.S., Kim J.-J., Lee D.W., Lee J.S., Lee D.S., Kim M.-S., Lyoo I.K., Cho M.J., Lee M.C. Neural correlates of clinical symptoms and cognitive dysfunctions in obsessive-compulsive disorder. Psychiatry Research 2003, 122:37-47.
46. Littell R.C., Milliken G.A., Stroup W.W., Wolfinger R.D., Schabenberber O. SAS for Mixed Models 2006, SAS Institute, Inc., Cary, NC. 2nd ed.
47. Marazziti D., Masala I., Rossi A., Hollander E., Presta S., Giannaccini G., Mazzoni M.R., Dell'Osso L., Lucacchini A., Cassano G.B. Increased inhibitory activity of protein kinase C on the serotonin transporter in OCD. Neuropsychobiology 2000, 41:171-177.
48. Menzies L., Achard S., Chamberlain S.R., Fineberg N., Chen C.H., del Campo N., Sahakian B.J., Robbins T.W., Bullmore E. Neurocognitive endophenotypes of obsessive-compulsive disorder. Brain 2007, 130:3223-3236.
49. Mohamed M.A., Smith M.A., Schlund M.W., Nestadt G., Barker P.B., Hoehn-Saric R. Proton magnetic resonance spectroscopy in obsessive-compulsive disorder: a pilot investigation comparing treatment responders and non-responders. Psychiatry Research: Neuroimaging 2007, 156:175-179.
50. Mollard E., Cottraux J., Bouvard M. Version française de l'échelle d'obsession compulsion de Yale-Brown [French version of the Yale-Brown Obsessive Compulsive Scale]. L'Encephale 1989, 15:335-341.
51. Moritz S., Birkner C., Kloss M., Jacobsen D., Fricke S., Bothern A., Hand I. Impact of comorbid depressive symptoms on neuropsychological performance in obsessive-compulsive disorder. Journal of Abnormal Psychology 2001, 110:653-657.
52. Mu J., Xie P., Yang Z.S., Yang D.L., Lv F.J., Luo T.Y., Li Y. (1)H magnetic resonance spectroscopy study of thalamus in treatment resistant depressive patients. Neuroscience Letters 2007, 425:49-52.
53. Nordahl T.E., Semple W.E., Gross M., Mellman T.A., Stein M.B., Goyer P., King A.C., Uhde T.W., Cohen R.M. Cerebral glucose metabolic differences in patients with panic disorder. Neuropsychopharmacology: Official Publication of the American College of Neuropsychopharmacology 1990, 3:261-272.
54. Pfund Z., Chugani D.C., Juhasz C., Muzik O., Chugani H.T., Wilds I.B., Seraji-Bozorgzad N., Moore G.J. Evidence for coupling between glucose metabolism and glutamate cycling using FDG PET and 1H magnetic resonance spectroscopy in patients with epilepsy. Journal of Cerebral Blood Flow and Metabolism: Official Journal of the International Society of Cerebral Blood Flow and Metabolism 2000, 20:871-878.
55. Provencher S.W. Estimation of metabolite concentrations from localized in vivo proton NMR spectra. Magnetic Resonance in Medicine: Official Journal of the Society of Magnetic Resonance in Medicine 1993, 30:672-679.
56. Quinn G., Keough M. Experimental design and data analysis for biologists 2002, Cambridge University Press, UK.
57. Rauch S.L., Jenike M.A., Alpert N.M., Baer L., Breiter H.C., Savage C.R., Fischman A.J. Regional cerebral blood flow measured during symptom provocation in obsessive-compulsive disorder using oxygen 15-labeled carbon dioxide and positron emission tomography. Archives of General Psychiatry 1994, 51:62-70.
58. Rauch S.L., Savage C.R., Alpert N.M., Fischman A.J., Jenike M.A. The functional neuroanatomy of anxiety: a study of three disorders using positron emission tomography and symptom provocation. Biological Psychiatry 1997, 42:446-452.
59. Reiman E.M., Raichle M.E., Butler F.K., Herscovitch P., Robins E. A focal brain abnormality in panic disorder, a severe form of anxiety. Nature 1984, 310:683-685.
60. Rosenberg D.R., MacMaster F.P., Keshavan M.S., Fitzgerald K.D., Stewart C.M., Moore G.J. Decrease in caudate glutamatergic concentrations in pediatric obsessive-compulsive disorder patients taking paroxetine. Journal of the American Academy of Child and Adolescent Psychiatry 2000, 39:1096-1103.
61. Rosenberg D.R., Amponsah A., Sullivan A., MacMillan S., Moore G.J. Increased medial thalamic choline in pediatric obsessive-compulsive disorder as detected by quantitative in vivo spectroscopic imaging. Journal of Child Neurology 2001, 16:636-641.
62. Rosenberg D.R., Mirza Y., Russell A., Tang J., Smith J.M., Banerjee S.P., Rose M., Ivey J., Boyd C., Moore G.J. Reduced anterior cingulate glutamatergic concentrations in childhood OCD and major depression versus healthy controls. Journal of the American Academy of Child and Adolescent Psychiatry 2004, 43:1146-1153.
63. Roth R.M., Saykin A.J., Flashman L.A., Pixley H.S., West J.D., Mamourian A.C. Event-related functional magnetic resonance imaging of response inhibition in obsessive-compulsive disorder. Biological Psychiatry 2007, 62:901-909.
64. Rothman D.L., Behar K.L., Hyder F., Shulman R.G. In vivo NMR studies of the glutamate neurotransmitter flux and neuroenergetics: implications for brain function. Annual Review of Physiology 2003, 65:401-427.
65. Rubin R.T., Ananth J., Villanueva-Meyer J., Trajmar P.G., Mena I. Regional 133xenon cerebral blood flow and cerebral 99mTc-HMPAO uptake in patients with obsessive-compulsive disorder before and during treatment. Biological Psychiatry 1995, 38:429-437.
66. Russell A., Cortese B., Lorch E., Ivey J., Banerjee S.P., Moore G.J., Rosenberg D.R. Localized functional neurochemical marker abnormalities in dorsolateral prefrontal cortex in pediatric obsessive-compulsive disorder. Journal of Child and Adolescent Psychopharmacology 2003, 13(Suppl 1):S31-S38.
67. Sapolsky R.M. The possibility of neurotoxicity in the hippocampus in major depression: a prime on neuron death. Biological Psychiatry 2000, 48:755-765.
68. Saxena S. Neuroimaging and the pathophysiology of obsessive compulsive disorder. Neuroimaging in Psychiatry 2003, 191-224. Martin Dunitz, UK. C. Fu, C. Senior, T. Russell, D. Weinberger, R. Murray (Eds.).
69. Saxena S., Rauch S.L. Functional neuroimaging and the neuroanatomy of obsessive-compulsive disorder. The Psychiatric Clinics of North America 2000, 23:563-586.
70. Saxena S., Bota R.G., Brody A.L. Brain-behavior relationships in obsessive-compulsive disorder. Seminars in Clinical Neuropsychiatry 2001, 6:82-101.
71. Seedat S., Stein D.J., Harvey B.H. Inositol in the treatment of trichotillomania and compulsive skin picking. The Journal of Clinical Psychiatry 2001, 62:60-61.
72. Smith E.A., Russell A., Lorch E., Banerjee S.P., Rose M., Ivey J., Bhandari R., Moore G.J., Rosenberg D.R. Increased medial thalamic choline found in pediatric patients with obsessive-compulsive disorder versus major depression or healthy control subjects: a magnetic resonance spectroscopy study. Biological Psychiatry 2003, 54:1399-1405.
73. Starck G., Ljungberg M., Nilsson M., Jönsson L., Lundberg S., Ivarsson T., Ribbelin S., Ekholm S., Carlsson A., Forssell-Aronsson E., Carlsson M.L. Journal of Neural Transmission 2008, 115:1051-1062.
74. Steketee G., Eisen J., Dyck I., Warshaw M., Rasmussen S. Predictors of course in obsessive-compulsive disorder. Psychiatry Research 1999, 89:229-238.
75. Sumitani S., Harada M., Kubo H., Ohmori T. Proton magnetic resonance spectroscopy reveals an abnormality in the anterior cingulate of a subgroup of obsessive-compulsive disorder patients. Psychiatry Research: Neuroimaging 2007, 154:85-92.
76. 2+ elevation in cultured rat hippocampal neurons. Journal of Neurochemistry 2002, 83:1441-1451.
77. Tillfors M., Furmark T., Marteinsdottir I., Fischer H., Pissiota A., Långström B., Fredrikson M. Cerebral blood flow in subject with social phobia during stressful speaking tasks: a PET study. American Journal of Psychiatry 2001, 158:1220-1226.
78. Whiteside S.P., Port J.D., Deacon B.J., Abramowitz J.S. A magnetic resonance spectroscopy investigation of obsessive-compulsive disorder and anxiety. Psychiatry Research: Neuroimaging 2006, 146:137-147.
79. Wignall E.L., Dickson J.M., Vaughan P., Farrow T.F.D., Wilkinson I.D., Hunter M.D., Woodruff P.W. Smaller hippocampal volume in patients with recent-onset posttraumatic stress disorder. Biological Psychiatry 2004, 56:832-836.
80. Winter H., Irle E. Hippocampal volume in adult burn patients with and without posttraumatic stress disorder. The American Journal of Psychiatry 2004, 161:2194-2200.
81. Wolfson M., Bersudsky Y., Hertz E., Berkin V., Zinger E., Hertz L. A model of inositol compartmentation in astrocytes based upon efflux kinetics and slow inositol depletion after uptake inhibition. Neurochemical Research 2000, 25:977-982.
82. Woolley J., Heyman I., Brammer M., Frampton I., McGuire P.K., Rubia K. Brain activation in paediatric obsessive compulsive disorder during tasks of inhibitory control. The British Journal of Psychiatry: The Journal of Mental Science 2008, 192:25-31.
83. Yücel M., Harrison B.J., Wood S.J., Fornito A., Wellard R.M., Pujol J., Clarke K., Phillips M.L., Kyrios M., Velakoulis D., Pantelis C. Functional and biochemical alterations of the medial frontal cortex in obsessive-compulsive disorder. Archives of General Psychiatry 2007, 64:946-955.
84. Yücel M., Wood S.J., Wellard R.M., Harrison B.J., Fornito A., Pujol J., Velakoulis D., Pantelis C. Anterior cingulate glutamate-glutamine levels predict symptom severity in women with obsessive-compulsive disorder. The Australian and New Zealand Journal of Psychiatry 2008, 42:467-477.